Physician
Family Medicine
Dr. Mark A. Hull, MD
|
|
Give Review
Mark Hull is an expert in the field of Family Medicine. He went to University of Iowa Carver College of Medicine. University of Iowa Carver College of Medicine is ranked 29 in research and 16 in primary care medicine Mark A. Hull, MD has written publications. He has 49 publications published with PubMed. The lastest paper is: 'Expression of basic fibroblast growth factor in intact and ulcerated human gastric mucosa.' Mark A. Hull, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- High-frequency ultrasound for in vivo measurement of colon wall thickness in mice.
- Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer.
- Aspirin in the chemoprevention of colorectal neoplasia: an overview.
- Altered intestinal epithelium-associated lymphocyte repertoires and function in ApcMin/+ mice.
- Chemoprevention in gastroenterology.
- Omega-3 polyunsaturated fatty acids.
- Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer.
- Colonoscopy for colonic wall thickening at computed tomography: a worthwhile pursuit?
- Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity:...
- Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells.
- Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis.
- Atherosclerosis and colorectal carcinogenesis: shared risk factors or common pathogenesis?
- Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas.
- Effect of weight loss on proinflammatory state of mononuclear cells in obese women.
- Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse.
- Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass.
- Lack of interleukin-4 receptor alpha chain-dependent signalling promotes azoxymethane-induced colorectal aberrant crypt focus formation in Balb/c mice.
- Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells.
- Immunohistochemical measurement of endothelial cell apoptosis and proliferation in formalin-fixed, paraffin-embedded human cancer tissue.
- Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastases.
- Regulation of stromal cell cyclooxygenase-2 in the ApcMin/+ mouse model of intestinal tumorigenesis.
- Macrophage migration inhibitory factor promotes intestinal tumorigenesis.
- Cyclooxygenase-2: how good is it as a target for cancer chemoprevention?
- Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer?
- Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells.
- Effect of nonsteroidal anti-inflammatory drugs on beta-catenin protein levels and catenin-related transcription in human colorectal cancer cells.
- Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis.
- Fulminant Crohn''s colitis after allogeneic stem cell transplantation.
- The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases.
- Activity of the non-steroidal anti-inflammatory drug indomethacin against colorectal cancer.
- Activation of peroxisome proliferator-activated receptor gamma does not explain the antiproliferative activity of the nonsteroidal anti-inflammatory drug indomethacin ...
- Interstitial cell cyclooxygenase-2 expression is associated with increased angiogenesis in human sporadic colorectal adenomas.
- Paracrine cyclooxygenase-2-mediated signalling by macrophages promotes tumorigenic progression of intestinal epithelial cells.
- Percutaneous endoscopic gastrostomy (PEG): change in practice since 1988.
- Analysis of cyclooxygenase expression in human colorectal adenomas.
- Variable use of endoscopic haemostasis in the management of bleeding peptic ulcers.
- Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells.
- Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc(Min/+) mouse.
- Cyclooxygenase-2 expression in colorectal cancer liver metastases.
- The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.
- Localization of cyclooxygenase-2 in human sporadic colorectal adenomas.
- Non-steroidal anti-inflammatory drugs inhibit Helicobacter pylori-induced human neutrophil reactive oxygen metabolite production in vitro.
- Expression of cyclooxygenase 1 and 2 by human gastric endothelial cells.
- Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.
- Expression of basic fibroblast growth factor in intact and ulcerated human gastric mucosa.
- Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration.
- Isolation and culture of human gastric endothelial cells.
- Basic fibroblast growth factor treatment for non-steroidal anti-inflammatory drug associated gastric ulceration.
Schools
Roy J Lucille a Carver College Of Medicine At University Of Iowa
Mercy St Lukes Hospital
Doctors Specialties
- Anesthesiology
- Family Medicine
Accepted Insurances
- Choice Plus POS II
- American Republic
- Blue Cross Blue Shield
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- CoreSource
- Coventry Health Care
- Coventry Health Care of Illinois PPO
- Health and Life PPO
- Platinum PPO
- Coventry Health Care of Iowa PPO
- Coventry Health Care of Missouri PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- Health Alliance PPO
- Choice Care PPO
- Medicare MCR
- Pekin Insurance
- Thrivent Financial
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Alliance Select
Education
-
University of Iowa Carver College of Medicine
Drug Facts
| NPI NUMBER | 1275538746 | |
| NPPES Provider LastName | HULL | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 528065403 | |
| NPPES Provider State | IA | |
| Specialty Description | Family Practice | |
| Total Claim Count | 310.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275538746 |
| Last Name Of The Provider | HULL |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Renee D. Lass, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph E. Bergstrom Sr., DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Devin S. Wenrich, MD |
|
|
Dr. Kimberly A. Hayden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen T. Delessio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Gimbel III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary E. Shanks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ricky L. Sedgwick, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey J. Joyce, MD |
|
|
Dr. Mitchell C. Ruffcorn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Candyce L. Ackland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Regan A. Keeney, DO |
|
|
Dr. Carrie D. Stripling, MD |
|
|
Dr. Johnny E. Brian Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Swanson, MD
This Doctor is OpenDoctor Recommended.
|